MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-152

  1. 11,103 Posts.
    lightbulb Created with Sketch. 696
    They certainly have more well-educated numbers to consider now judging what they do or don't do. Not just some little upstart Aussie company they can slow and slow and slow.

    I was also wondering if the FDA wanted this to protect themselves as well. Which way is the lawyer pressure going at this point of time.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.